Related Experiment Video
Updated: Jul 1, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[Importance of prevention of infectious complications in pediatric hematologic-oncologic patients]
1Zentrum für Kinderheilkunde des Universitätsklinikums BonnAbteilung Pädiatrische Hämatologie/Onkologie, Bonn, Germany. fleischh@mailer.meb.uni-bonn.de
Insights
Preventive strategies, early diagnosis, and antibiotic therapy have significantly improved survival for children with cancer by controlling infections. This review highlights infection prevention in immunocompromised pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Hematology
Background:
- Severe infectious complications pose a significant threat to children with cancer.
- Survival rates in pediatric cancer patients have improved over the last two decades.
- Immunocompromised status in these patients increases susceptibility to infections.
Purpose of the Study:
- To overview the importance of preventing infectious complications in immunocompromised pediatric patients with hematologic or oncologic diseases.
- To discuss the challenges in managing infections in this vulnerable age group.
- To review anti-infectious prophylaxis strategies.
Main Methods:
- Literature review focusing on infection control in pediatric oncology.
- Analysis of data on survival improvements over the past 20 years.
- Consideration of pathogen acquisition, spread, and causative microorganisms.
Main Results:
- Preventive strategies, early diagnosis, and empiric broad-spectrum antibiotic therapy have markedly improved survival.
- Effective control of infections is crucial for better outcomes in pediatric cancer patients.
- Understanding pathogen dynamics is key to successful management.
Conclusions:
- Infection prevention is paramount in improving survival for pediatric cancer patients.
- Specific challenges related to pathogen acquisition and spread in this age group require tailored approaches.
- Anti-infectious prophylaxis remains a critical component of care.
Abstract:
The control of severe infectious complications by preventive strategies, early diagnosis of infections and empiric broad-spectrum antibiotic therapy contributed to a marked improvement of survival in children with cancer over the last 20 years. This article overviews of the importance of prevention of infectious complications in immunocompromised pediatric patients with hematologic or oncologic diseases. The particular challenge of this age group with respect to the acquisition and the spread of pathogens, the spectrum of causative microorganisms and the principal issues of anti-infectious prophylaxis are considered.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pharmacokinetics in Pediatric Patients: Drug Excretion

